APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Intestinal Anti-infective Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Intestinal Anti-infective Drugs Market Outlook and Growth Opportunities 2026

27 December 2025212 pages

Choose your research edition.

Industry ResearchIntestinal Anti-infective Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Intestinal Anti-infective Drugs Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Intestinal Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intestinal Anti-infective Drugs Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Intestinal Anti-infective Drugs Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Intestinal Anti-infective Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Intestinal Anti-infective Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Intestinal Anti-infective Drugs market include Chongqing Sino Biopharmaceutical Co., Ltd., Chongqing Laimi Pharmaceutical Co., Ltd., Zhejiang Deer Pharmaceutical Co., Ltd., Yunnan Weihe Pharmaceutical Co., Ltd., Yangzhou Sanyao Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Teyi Pharmaceutical Group Co., Ltd., Sichuan Ziligong Pharmaceutical Co., Ltd. and Shaanxi Kaiyuan Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intestinal Anti-infective Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intestinal Anti-infective Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intestinal Anti-infective Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intestinal Anti-infective Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Intestinal Anti-infective Drugs Segment by Company

Chongqing Sino Biopharmaceutical Co., Ltd.

Chongqing Laimi Pharmaceutical Co., Ltd.

Zhejiang Deer Pharmaceutical Co., Ltd.

Yunnan Weihe Pharmaceutical Co., Ltd.

Yangzhou Sanyao Pharmaceutical Co., Ltd.

Tiansheng Pharmaceutical Group Co., Ltd.

Teyi Pharmaceutical Group Co., Ltd.

Sichuan Ziligong Pharmaceutical Co., Ltd.

Shaanxi Kaiyuan Pharmaceutical Co., Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

Nanjing Chengong Pharmaceutical Co., Ltd.

Lingyuan Pharmaceutical Co., Ltd.

Jiangxi Pharmaceutical Co., Ltd.

Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.

Jilin Jibang Pharmaceutical Co., Ltd.

Jilin Fukang Pharmaceutical Co., Ltd.

Hubei Hendi Pharmaceutical Co., Ltd.

Hainan Hailing Chemical Pharmaceutical Co., Ltd.

Fujian Sanming Tiantai Pharmaceutical Co., Ltd.

Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.

Vox Nutrition

Teva Pharmaceuticals

Salix Pharmaceuticals

Otto Chemie Pvt Ltd

Medikonda Nutrients

Botanic Healthcare

AdvaCare Pharma

Intestinal Anti-infective Drugs Segment by Type

Neomycin

Berberine

Rifaximin

Intestinal Anti-infective Drugs Segment by Application

Pharmacy

Hospital

Clinic

Other

Intestinal Anti-infective Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Intestinal Anti-infective Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Intestinal Anti-infective Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intestinal Anti-infective Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Intestinal Anti-infective Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intestinal Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intestinal Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intestinal Anti-infective Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intestinal Anti-infective Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intestinal Anti-infective Drugs industry.

Chapter 3: Detailed analysis of Intestinal Anti-infective Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Intestinal Anti-infective Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Intestinal Anti-infective Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intestinal Anti-infective Drugs Industry Trends Table 2. Intestinal Anti-infective Drugs Industry Drivers Table 3. Intestinal Anti-infective Drugs Industry Opportunities and Challenges Table 4. Intestinal Anti-infective Drugs Industry Restraints Table 5. Global Intestinal Anti-infective Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intestinal Anti-infective Drugs Revenue Share by Company (2021-2026) Table 7. Global Intestinal Anti-infective Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Intestinal Anti-infective Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Intestinal Anti-infective Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Intestinal Anti-infective Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Intestinal Anti-infective Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Intestinal Anti-infective Drugs Company, Product Type & Application Table 13. Global Intestinal Anti-infective Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Intestinal Anti-infective Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Neomycin Table 18. Significant Companies of Berberine Table 19. Significant Companies of Rifaximin Table 20. Global Intestinal Anti-infective Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Intestinal Anti-infective Drugs Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Intestinal Anti-infective Drugs Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Intestinal Anti-infective Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Intestinal Anti-infective Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Intestinal Anti-infective Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Intestinal Anti-infective Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Intestinal Anti-infective Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Intestinal Anti-infective Drugs Sales Value Share by Type (2021-2026) Table 29. Global Intestinal Anti-infective Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pharmacy Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Other Table 34. Global Intestinal Anti-infective Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Intestinal Anti-infective Drugs Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Intestinal Anti-infective Drugs Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Intestinal Anti-infective Drugs Sales Volume Share by Application (2021-2026) Table 38. Global Intestinal Anti-infective Drugs Sales Volume Share by Application (2027-2032) Table 39. Global Intestinal Anti-infective Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Intestinal Anti-infective Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Intestinal Anti-infective Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Intestinal Anti-infective Drugs Sales Value Share by Application (2021-2026) Table 43. Global Intestinal Anti-infective Drugs Sales Value Share by Application (2027-2032) Table 44. Global Intestinal Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Intestinal Anti-infective Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Intestinal Anti-infective Drugs Sales Market Share by Region (2021-2026) Table 47. Global Intestinal Anti-infective Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Intestinal Anti-infective Drugs Sales Market Share by Region (2027-2032) Table 49. Global Intestinal Anti-infective Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Intestinal Anti-infective Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Intestinal Anti-infective Drugs Sales Value Share by Region (2021-2026) Table 52. Global Intestinal Anti-infective Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Intestinal Anti-infective Drugs Sales Value Share by Region (2027-2032) Table 54. Global Intestinal Anti-infective Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Intestinal Anti-infective Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Intestinal Anti-infective Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Intestinal Anti-infective Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 59. Global Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2026) Table 60. Global Intestinal Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Intestinal Anti-infective Drugs Sales Market Share by Country (2027-2032) Table 62. Global Intestinal Anti-infective Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Intestinal Anti-infective Drugs Sales Value Market Share by Country (2021-2026) Table 64. Global Intestinal Anti-infective Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Intestinal Anti-infective Drugs Sales Value Market Share by Country (2027-2032) Table 66. Chongqing Sino Biopharmaceutical Co., Ltd. Company Information Table 67. Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview Table 68. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 70. Chongqing Sino Biopharmaceutical Co., Ltd. Recent Development Table 71. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information Table 72. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview Table 73. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 75. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Development Table 76. Zhejiang Deer Pharmaceutical Co., Ltd. Company Information Table 77. Zhejiang Deer Pharmaceutical Co., Ltd. Business Overview Table 78. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 80. Zhejiang Deer Pharmaceutical Co., Ltd. Recent Development Table 81. Yunnan Weihe Pharmaceutical Co., Ltd. Company Information Table 82. Yunnan Weihe Pharmaceutical Co., Ltd. Business Overview Table 83. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 85. Yunnan Weihe Pharmaceutical Co., Ltd. Recent Development Table 86. Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information Table 87. Yangzhou Sanyao Pharmaceutical Co., Ltd. Business Overview Table 88. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 90. Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Development Table 91. Tiansheng Pharmaceutical Group Co., Ltd. Company Information Table 92. Tiansheng Pharmaceutical Group Co., Ltd. Business Overview Table 93. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 95. Tiansheng Pharmaceutical Group Co., Ltd. Recent Development Table 96. Teyi Pharmaceutical Group Co., Ltd. Company Information Table 97. Teyi Pharmaceutical Group Co., Ltd. Business Overview Table 98. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 100. Teyi Pharmaceutical Group Co., Ltd. Recent Development Table 101. Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information Table 102. Sichuan Ziligong Pharmaceutical Co., Ltd. Business Overview Table 103. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 105. Sichuan Ziligong Pharmaceutical Co., Ltd. Recent Development Table 106. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information Table 107. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview Table 108. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 110. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Development Table 111. Shandong Xinhua Pharmaceutical Co., Ltd. Company Information Table 112. Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview Table 113. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 115. Shandong Xinhua Pharmaceutical Co., Ltd. Recent Development Table 116. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information Table 117. Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview Table 118. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 120. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Development Table 121. Lingyuan Pharmaceutical Co., Ltd. Company Information Table 122. Lingyuan Pharmaceutical Co., Ltd. Business Overview Table 123. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 125. Lingyuan Pharmaceutical Co., Ltd. Recent Development Table 126. Jiangxi Pharmaceutical Co., Ltd. Company Information Table 127. Jiangxi Pharmaceutical Co., Ltd. Business Overview Table 128. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 130. Jiangxi Pharmaceutical Co., Ltd. Recent Development Table 131. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information Table 132. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Business Overview Table 133. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 135. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Development Table 136. Jilin Jibang Pharmaceutical Co., Ltd. Company Information Table 137. Jilin Jibang Pharmaceutical Co., Ltd. Business Overview Table 138. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 140. Jilin Jibang Pharmaceutical Co., Ltd. Recent Development Table 141. Jilin Fukang Pharmaceutical Co., Ltd. Company Information Table 142. Jilin Fukang Pharmaceutical Co., Ltd. Business Overview Table 143. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 145. Jilin Fukang Pharmaceutical Co., Ltd. Recent Development Table 146. Hubei Hendi Pharmaceutical Co., Ltd. Company Information Table 147. Hubei Hendi Pharmaceutical Co., Ltd. Business Overview Table 148. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 150. Hubei Hendi Pharmaceutical Co., Ltd. Recent Development Table 151. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information Table 152. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview Table 153. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 155. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Development Table 156. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information Table 157. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Business Overview Table 158. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 160. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Recent Development Table 161. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information Table 162. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Business Overview Table 163. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 165. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Development Table 166. Vox Nutrition Company Information Table 167. Vox Nutrition Business Overview Table 168. Vox Nutrition Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Vox Nutrition Intestinal Anti-infective Drugs Product Portfolio Table 170. Vox Nutrition Recent Development Table 171. Teva Pharmaceuticals Company Information Table 172. Teva Pharmaceuticals Business Overview Table 173. Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio Table 175. Teva Pharmaceuticals Recent Development Table 176. Salix Pharmaceuticals Company Information Table 177. Salix Pharmaceuticals Business Overview Table 178. Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio Table 180. Salix Pharmaceuticals Recent Development Table 181. Otto Chemie Pvt Ltd Company Information Table 182. Otto Chemie Pvt Ltd Business Overview Table 183. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 184. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolio Table 185. Otto Chemie Pvt Ltd Recent Development Table 186. Medikonda Nutrients Company Information Table 187. Medikonda Nutrients Business Overview Table 188. Medikonda Nutrients Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 189. Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolio Table 190. Medikonda Nutrients Recent Development Table 191. Botanic Healthcare Company Information Table 192. Botanic Healthcare Business Overview Table 193. Botanic Healthcare Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 194. Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolio Table 195. Botanic Healthcare Recent Development Table 196. AdvaCare Pharma Company Information Table 197. AdvaCare Pharma Business Overview Table 198. AdvaCare Pharma Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 199. AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolio Table 200. AdvaCare Pharma Recent Development Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Intestinal Anti-infective Drugs Distributors List Table 204. Intestinal Anti-infective Drugs Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Intestinal Anti-infective Drugs Product Image Figure 2. Global Intestinal Anti-infective Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intestinal Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Intestinal Anti-infective Drugs Sales (2021-2032) & (K Units) Figure 5. Global Intestinal Anti-infective Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Intestinal Anti-infective Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Neomycin Image Figure 10. Berberine Image Figure 11. Rifaximin Image Figure 12. Global Intestinal Anti-infective Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Intestinal Anti-infective Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Intestinal Anti-infective Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Intestinal Anti-infective Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Intestinal Anti-infective Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Intestinal Anti-infective Drugs Sales Value Share by Type (2021-2032) Figure 18. Pharmacy Image Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Other Image Figure 22. Global Intestinal Anti-infective Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Intestinal Anti-infective Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Intestinal Anti-infective Drugs Sales Volume Share by Application (2021-2032) Figure 25. Global Intestinal Anti-infective Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Intestinal Anti-infective Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Intestinal Anti-infective Drugs Sales Value Share by Application (2021-2032) Figure 28. Global Intestinal Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Intestinal Anti-infective Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Intestinal Anti-infective Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Intestinal Anti-infective Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Intestinal Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. North America Intestinal Anti-infective Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Intestinal Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Intestinal Anti-infective Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Intestinal Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Intestinal Anti-infective Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Intestinal Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. South America Intestinal Anti-infective Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Intestinal Anti-infective Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Intestinal Anti-infective Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Intestinal Anti-infective Drugs Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Intestinal Anti-infective Drugs Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Neomycin
  • Berberine
  • Rifaximin
Applications
  • Pharmacy
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Sino Biopharmaceutical Co., Ltd.
  • Chongqing Laimi Pharmaceutical Co., Ltd.
  • Zhejiang Deer Pharmaceutical Co., Ltd.
  • Yunnan Weihe Pharmaceutical Co., Ltd.
  • Yangzhou Sanyao Pharmaceutical Co., Ltd.
  • Tiansheng Pharmaceutical Group Co., Ltd.
  • Teyi Pharmaceutical Group Co., Ltd.
  • Sichuan Ziligong Pharmaceutical Co., Ltd.
  • Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Nanjing Chengong Pharmaceutical Co., Ltd.
  • Lingyuan Pharmaceutical Co., Ltd.
  • Jiangxi Pharmaceutical Co., Ltd.
  • Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
  • Jilin Jibang Pharmaceutical Co., Ltd.
  • Jilin Fukang Pharmaceutical Co., Ltd.
  • Hubei Hendi Pharmaceutical Co., Ltd.
  • Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  • Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
  • Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
  • Vox Nutrition
  • Teva Pharmaceuticals
  • Salix Pharmaceuticals
  • Otto Chemie Pvt Ltd
  • Medikonda Nutrients
  • Botanic Healthcare
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intestinal Anti-infective Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Intestinal Anti-infective Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Intestinal Anti-infective Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Intestinal Anti-infective Drugs Market Dynamics
  1. 2.1 Intestinal Anti-infective Drugs Industry Trends
  2. 2.2 Intestinal Anti-infective Drugs Industry Drivers
  3. 2.3 Intestinal Anti-infective Drugs Industry Opportunities and Challenges
  4. 2.4 Intestinal Anti-infective Drugs Industry Restraints
3 Intestinal Anti-infective Drugs Market by Company
  1. 3.1 Global Intestinal Anti-infective Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Intestinal Anti-infective Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Intestinal Anti-infective Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Intestinal Anti-infective Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Intestinal Anti-infective Drugs Company Ranking (2024-2026)
  6. 3.6 Global Intestinal Anti-infective Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Intestinal Anti-infective Drugs Company Product Type and Application
  8. 3.8 Global Intestinal Anti-infective Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Intestinal Anti-infective Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Intestinal Anti-infective Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Intestinal Anti-infective Drugs Market by Type
  1. 4.1 Intestinal Anti-infective Drugs Type Introduction
  2. 4.1.1 Neomycin
  3. 4.1.2 Berberine
  4. 4.1.3 Rifaximin
  5. 4.2 Global Intestinal Anti-infective Drugs Sales Volume by Type
  6. 4.2.1 Global Intestinal Anti-infective Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Intestinal Anti-infective Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Intestinal Anti-infective Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Intestinal Anti-infective Drugs Sales Value by Type
  10. 4.3.1 Global Intestinal Anti-infective Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Intestinal Anti-infective Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Intestinal Anti-infective Drugs Sales Value Share by Type (2021-2032)
5 Intestinal Anti-infective Drugs Market by Application
  1. 5.1 Intestinal Anti-infective Drugs Application Introduction
  2. 5.1.1 Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Other
  6. 5.2 Global Intestinal Anti-infective Drugs Sales Volume by Application
  7. 5.2.1 Global Intestinal Anti-infective Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Intestinal Anti-infective Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Intestinal Anti-infective Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Intestinal Anti-infective Drugs Sales Value by Application
  11. 5.3.1 Global Intestinal Anti-infective Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Intestinal Anti-infective Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Intestinal Anti-infective Drugs Sales Value Share by Application (2021-2032)
6 Intestinal Anti-infective Drugs Regional Sales and Value Analysis
  1. 6.1 Global Intestinal Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intestinal Anti-infective Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Intestinal Anti-infective Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Intestinal Anti-infective Drugs Sales by Region (2027-2032)
  5. 6.3 Global Intestinal Anti-infective Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Intestinal Anti-infective Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Intestinal Anti-infective Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Intestinal Anti-infective Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Intestinal Anti-infective Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Intestinal Anti-infective Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Intestinal Anti-infective Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Intestinal Anti-infective Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Intestinal Anti-infective Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Intestinal Anti-infective Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Intestinal Anti-infective Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Intestinal Anti-infective Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Intestinal Anti-infective Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Intestinal Anti-infective Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Intestinal Anti-infective Drugs Sales Value Share by Country, 2025 VS 2032
7 Intestinal Anti-infective Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Intestinal Anti-infective Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intestinal Anti-infective Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Intestinal Anti-infective Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Intestinal Anti-infective Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Intestinal Anti-infective Drugs Sales by Country (2027-2032)
  6. 7.4 Global Intestinal Anti-infective Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Intestinal Anti-infective Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Intestinal Anti-infective Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Intestinal Anti-infective Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Intestinal Anti-infective Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Intestinal Anti-infective Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Sino Biopharmaceutical Co., Ltd.
  2. 8.1.1 Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  6. 8.1.5 Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Chongqing Laimi Pharmaceutical Co., Ltd.
  8. 8.2.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  12. 8.2.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Zhejiang Deer Pharmaceutical Co., Ltd.
  14. 8.3.1 Zhejiang Deer Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Zhejiang Deer Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  18. 8.3.5 Zhejiang Deer Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Yunnan Weihe Pharmaceutical Co., Ltd.
  20. 8.4.1 Yunnan Weihe Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Yunnan Weihe Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  24. 8.4.5 Yunnan Weihe Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Yangzhou Sanyao Pharmaceutical Co., Ltd.
  26. 8.5.1 Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Yangzhou Sanyao Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  30. 8.5.5 Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Tiansheng Pharmaceutical Group Co., Ltd.
  32. 8.6.1 Tiansheng Pharmaceutical Group Co., Ltd. Company Information
  33. 8.6.2 Tiansheng Pharmaceutical Group Co., Ltd. Business Overview
  34. 8.6.3 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  36. 8.6.5 Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments
  37. 8.7 Teyi Pharmaceutical Group Co., Ltd.
  38. 8.7.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
  39. 8.7.2 Teyi Pharmaceutical Group Co., Ltd. Business Overview
  40. 8.7.3 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  42. 8.7.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments
  43. 8.8 Sichuan Ziligong Pharmaceutical Co., Ltd.
  44. 8.8.1 Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Sichuan Ziligong Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  48. 8.8.5 Sichuan Ziligong Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  50. 8.9.1 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  54. 8.9.5 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Shandong Xinhua Pharmaceutical Co., Ltd.
  56. 8.10.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  60. 8.10.5 Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Nanjing Chengong Pharmaceutical Co., Ltd.
  62. 8.11.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  66. 8.11.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Lingyuan Pharmaceutical Co., Ltd.
  68. 8.12.1 Lingyuan Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Lingyuan Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  72. 8.12.5 Lingyuan Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Jiangxi Pharmaceutical Co., Ltd.
  74. 8.13.1 Jiangxi Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Jiangxi Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  78. 8.13.5 Jiangxi Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
  80. 8.14.1 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  84. 8.14.5 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Jilin Jibang Pharmaceutical Co., Ltd.
  86. 8.15.1 Jilin Jibang Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Jilin Jibang Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  90. 8.15.5 Jilin Jibang Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Jilin Fukang Pharmaceutical Co., Ltd.
  92. 8.16.1 Jilin Fukang Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Jilin Fukang Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  96. 8.16.5 Jilin Fukang Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Hubei Hendi Pharmaceutical Co., Ltd.
  98. 8.17.1 Hubei Hendi Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Hubei Hendi Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  102. 8.17.5 Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  104. 8.18.1 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  108. 8.18.5 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
  110. 8.19.1 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  114. 8.19.5 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
  116. 8.20.1 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information
  117. 8.20.2 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Business Overview
  118. 8.20.3 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  120. 8.20.5 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Developments
  121. 8.21 Vox Nutrition
  122. 8.21.1 Vox Nutrition Company Information
  123. 8.21.2 Vox Nutrition Business Overview
  124. 8.21.3 Vox Nutrition Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Vox Nutrition Intestinal Anti-infective Drugs Product Portfolio
  126. 8.21.5 Vox Nutrition Recent Developments
  127. 8.22 Teva Pharmaceuticals
  128. 8.22.1 Teva Pharmaceuticals Company Information
  129. 8.22.2 Teva Pharmaceuticals Business Overview
  130. 8.22.3 Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio
  132. 8.22.5 Teva Pharmaceuticals Recent Developments
  133. 8.23 Salix Pharmaceuticals
  134. 8.23.1 Salix Pharmaceuticals Company Information
  135. 8.23.2 Salix Pharmaceuticals Business Overview
  136. 8.23.3 Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio
  138. 8.23.5 Salix Pharmaceuticals Recent Developments
  139. 8.24 Otto Chemie Pvt Ltd
  140. 8.24.1 Otto Chemie Pvt Ltd Company Information
  141. 8.24.2 Otto Chemie Pvt Ltd Business Overview
  142. 8.24.3 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolio
  144. 8.24.5 Otto Chemie Pvt Ltd Recent Developments
  145. 8.25 Medikonda Nutrients
  146. 8.25.1 Medikonda Nutrients Company Information
  147. 8.25.2 Medikonda Nutrients Business Overview
  148. 8.25.3 Medikonda Nutrients Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolio
  150. 8.25.5 Medikonda Nutrients Recent Developments
  151. 8.26 Botanic Healthcare
  152. 8.26.1 Botanic Healthcare Company Information
  153. 8.26.2 Botanic Healthcare Business Overview
  154. 8.26.3 Botanic Healthcare Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolio
  156. 8.26.5 Botanic Healthcare Recent Developments
  157. 8.27 AdvaCare Pharma
  158. 8.27.1 AdvaCare Pharma Company Information
  159. 8.27.2 AdvaCare Pharma Business Overview
  160. 8.27.3 AdvaCare Pharma Intestinal Anti-infective Drugs Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolio
  162. 8.27.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intestinal Anti-infective Drugs Value Chain Analysis
  2. 9.1.1 Intestinal Anti-infective Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intestinal Anti-infective Drugs Sales Mode & Process
  6. 9.2 Intestinal Anti-infective Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intestinal Anti-infective Drugs Distributors
  9. 9.2.3 Intestinal Anti-infective Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst